Liquidia appoints Roger Jeffs as CEO; deGoa stays on board through Jan 31

Liquidia Corp

Roger Jeffs, Ph.D., appointed CEO effective Jan 3, 2022; replaces Damian deGoa who remains director through Jan 31.
Jeffs previously co-CEO/president of United Therapeutics (18 yrs); co-founder/vice chairman of Kriya Therapeutics.
Employment terms: $650k base salary, 50% annual bonus target, options for 1.68M shares (sign-on) and 0.93M shares (tranche 2).
DeGoa provided transition support; board chairman cited Jeffs' rare disease and pulmonary hypertension expertise.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Roger A. Jeffs, Ph.D.

Chief Executive Officer

LQDA · Liquidia Corp

Effective: 2022-01-03
Filed: January 4, 2022, 6:59 PM ET

Roger A. Jeffs, Ph.D. was appointed by the Board of Directors (the “Board”) of Liquidia Corporation, a Delaware corporation (the “Company”), as the Company’s Chief Executive Officer

Role change

Damian deGoa

Director

LQDA · Liquidia Corp

Effective: 2022-01-03
Successor: Roger A. Jeffs, Ph.D.
Filed: January 4, 2022, 6:59 PM ET

Mr. deGoa’s concurrent resignation as the Company’s Chief Executive Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Roger A. Jeffs, Ph.D. was appointed as Chief Executive Officer at Liquidia Corp.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

Roger A. Jeffs, Ph.D. was appointed by the Board of Directors (the “Board”) of Liquidia Corporation, a Delaware corporation (the “Company”), as the Company’s Chief Executive Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Damian deGoa resigned as Director at Liquidia Corp.

Action: resigned
Role: Director

Exact text from the filing

Mr. deGoa’s concurrent resignation as the Company’s Chief Executive Officer

View on SEC.gov

Liquidia Corp filing history →

Source: SEC EDGAR

accession 0001104659-22-000510

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.